[go: up one dir, main page]

FI20011465A0 - Pyridatsinonijohdannaisen uusi käyttö - Google Patents

Pyridatsinonijohdannaisen uusi käyttö

Info

Publication number
FI20011465A0
FI20011465A0 FI20011465A FI20011465A FI20011465A0 FI 20011465 A0 FI20011465 A0 FI 20011465A0 FI 20011465 A FI20011465 A FI 20011465A FI 20011465 A FI20011465 A FI 20011465A FI 20011465 A0 FI20011465 A0 FI 20011465A0
Authority
FI
Finland
Prior art keywords
new use
pyridazinone derivative
mammal
pyridazinone
derivative
Prior art date
Application number
FI20011465A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Heimo Haikala
Esa-Pekka Sandell
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20011465A priority Critical patent/FI20011465A0/fi
Publication of FI20011465A0 publication Critical patent/FI20011465A0/fi
Priority to CA002450821A priority patent/CA2450821A1/fr
Priority to AT02743320T priority patent/ATE350101T1/de
Priority to PCT/FI2002/000605 priority patent/WO2003004035A1/fr
Priority to EP02743320A priority patent/EP1401450B1/fr
Priority to JP2003510046A priority patent/JP2004535457A/ja
Priority to DE60217336T priority patent/DE60217336T2/de
Priority to ES02743320T priority patent/ES2278930T3/es
Priority to US10/750,846 priority patent/US20040180895A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20011465A 2001-07-04 2001-07-04 Pyridatsinonijohdannaisen uusi käyttö FI20011465A0 (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI20011465A FI20011465A0 (fi) 2001-07-04 2001-07-04 Pyridatsinonijohdannaisen uusi käyttö
CA002450821A CA2450821A1 (fr) 2001-07-04 2002-07-04 Utilisation nouvelle d'un derive de pyridazinone
AT02743320T ATE350101T1 (de) 2001-07-04 2002-07-04 Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens
PCT/FI2002/000605 WO2003004035A1 (fr) 2001-07-04 2002-07-04 Utilisation nouvelle d'un derive de pyridazinone
EP02743320A EP1401450B1 (fr) 2001-07-04 2002-07-04 Utilisation d'un derive de pyridazinone pour le traitement d'un infarctus congestif
JP2003510046A JP2004535457A (ja) 2001-07-04 2002-07-04 ピリダジノン誘導体の新しい用途
DE60217336T DE60217336T2 (de) 2001-07-04 2002-07-04 Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens
ES02743320T ES2278930T3 (es) 2001-07-04 2002-07-04 Uso de un derivado de la piridazinona en el tratamiento de una insuficiencia cardiaca congestiva.
US10/750,846 US20040180895A1 (en) 2001-07-04 2004-01-05 Use of a pyridazinone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011465A FI20011465A0 (fi) 2001-07-04 2001-07-04 Pyridatsinonijohdannaisen uusi käyttö

Publications (1)

Publication Number Publication Date
FI20011465A0 true FI20011465A0 (fi) 2001-07-04

Family

ID=8561590

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011465A FI20011465A0 (fi) 2001-07-04 2001-07-04 Pyridatsinonijohdannaisen uusi käyttö

Country Status (9)

Country Link
US (1) US20040180895A1 (fr)
EP (1) EP1401450B1 (fr)
JP (1) JP2004535457A (fr)
AT (1) ATE350101T1 (fr)
CA (1) CA2450821A1 (fr)
DE (1) DE60217336T2 (fr)
ES (1) ES2278930T3 (fr)
FI (1) FI20011465A0 (fr)
WO (1) WO2003004035A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
JP6688295B2 (ja) * 2014-10-15 2020-04-28 オリオン コーポレーション 運動ニューロン病（例えばａｌｓ）の治療における使用のためのレボシメンダン
WO2021001601A1 (fr) 2019-07-01 2021-01-07 Orion Corporation Procédés d'administration de(r)-n-[4-(1,4,5,6-tétrahydro-6-oxo-3-pyridazinyl)phényl]acétamide
US11969424B2 (en) 2019-12-16 2024-04-30 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
US4517310A (en) * 1981-07-28 1985-05-14 Berlex Laboratories, Inc. N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and use thereof as a cardiotonic agent
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
FI973804A7 (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
US5905078A (en) * 1998-06-19 1999-05-18 Orion Corporation Use of a pyridazinone derivative
FI20011464A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Yhdistelmäterapia sydämen vajaatoiminnan hoitoon

Also Published As

Publication number Publication date
ATE350101T1 (de) 2007-01-15
DE60217336D1 (de) 2007-02-15
US20040180895A1 (en) 2004-09-16
ES2278930T3 (es) 2007-08-16
EP1401450B1 (fr) 2007-01-03
JP2004535457A (ja) 2004-11-25
EP1401450A1 (fr) 2004-03-31
CA2450821A1 (fr) 2003-01-16
WO2003004035A1 (fr) 2003-01-16
DE60217336T2 (de) 2007-10-04

Similar Documents

Publication Publication Date Title
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
DE60022504D1 (de) Phenoxypropylamin-derivate
EA200300621A1 (ru) Биарильные производные никотинамида, полезные в качестве ингибиторов изоферментов pde4
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
TR200000060T2 (tr) Bir N-fenil-2-pirimidinamin türevinin kristal modifikasyonu ve yapım işlemleri ve kullanımı.
FI970148A0 (fi) Heterosyklisten yhdisteiden käyttö dopamiini-D3-ligandeina
JP2006502183A5 (fr)
ES2189721T3 (es) Inhibidores de proteasa retroviral.
EA200200769A1 (ru) Ингибиторы гиразы и их применение
NO992282D0 (no) Benzonaftyridiner som bronkialterapentika
EA200300067A1 (ru) Кристаллическая форма целекоксиба
NO970164D0 (no) Anvendelse av tiazol- og tiadiazolforbindelser som D3 - dopaminreseptorligander
YU32196A (sh) Upotreba jedinjenja za pripremanje leka korisnog za inhibiranje migracije vaskularnih ćelija glatkog mišića
HUP0004725A2 (hu) 2-[3,5-Bisz-(trifluor-metil)-fenil]-N-metil-N-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-izobutiramid
DE60127537D1 (de) VERWENDUNG VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLOÄ1,5-bÜPYRIDAZINE ZUR BEHANDLUNG VON NICHTULZERATIVER DYSPEPSIE
FI20011465A0 (fi) Pyridatsinonijohdannaisen uusi käyttö
HRP20040230B1 (hr) Agonisti muskarina
NO20002655L (no) 5-(2-imidazolinylamino) -benzimidazol derivater, fremstilling og anvendelse derav som <alfa>-adrenoceptoragonister med forbedret metabolisk stabilitet
ATE240321T1 (de) 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
EE200000755A (et) Püridasinooni derivaadi uus kasutusvõimalus
DE69103968D1 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
ATE332695T1 (de) Pyrimidin-derivate als selektive inhibitoren von cox-2
DE69402935D1 (de) Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
ATE145206T1 (de) Oxindol 1-(n-(alkoxycarbonyl)>carboxamide und 1- (n-carboxamido>carboxamide als antiinflammatorische wirkstoffe
SE9902387D0 (sv) New pharmaceutically active compounds